🔗 Visit the ClinicalTrials.gov page for NCT00451880
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Targeting BRAF for patients with melanoma. | Br J Cancer | 2010 | 1.56 |
| 2 | Melanoma: new insights and new therapies. | J Invest Dermatol | 2012 | 1.54 |
| 3 | B-Raf and the inhibitors: from bench to bedside. | J Hematol Oncol | 2013 | 1.14 |
| 4 | BRAF vs RAS oncogenes: are mutations of the same pathway equal? Differential signalling and therapeutic implications. | Oncotarget | 2014 | 0.92 |
| 5 | Effects of BRAF mutations and BRAF inhibition on immune responses to melanoma. | Mol Cancer Ther | 2014 | 0.92 |